Aprepitant Impurity B Enantiomer HCl(183901-47-5)
- Name: Aprepitant Impurity B Enantiomer HCl
- Synonyms:183901-47-5;Aprepitant Impurity B Enantiomer HCl;(2R,3S)-4-benzyl-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholine;hydrochloride;MORPHOLINE, 2-[(1R)-1-[3,5-BIS(TRIFLUOROMETHYL)PHENYL]ETHOXY]-3-(4-FLUOROPHENYL)-4-(PHENYLMETHYL)-, HYDROCHLORIDE, (2R,3S)- (9CI);DTXSID50724789;(2R,3S)-4-Benzyl-2-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)morpholine--hydrogen chloride (1/1);Morpholine, 2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-(phenylmethyl)-, hydrochloride, (2R,3S)-;Morpholine,2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-(phenylmethyl)-,hydrochloride,(2R,3S)-
- Molecular Formula:C27H25ClF7NO2
- Molecular Weight:563.9
- CAS Registry Number:183901-47-5
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.183901-47-5 Aprepitant Impurity B Enantiomer HCl
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:Aprepitant Impurity B Enantiomer HCl
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.183901-47-5 Aprepitant Impurity 1 Enantiomer HCl
Assay:95%+ or 98%+ Appearance:solid Package:10mg/25mg/50mg/100mg/1000mg/5000mg Storage:short-term storage normal temperature. long-term storage 2-8 鈩?nbsp;Transportation:express and sea transport and air freight Application:for drug impurity for drug standards,for drug research and development銆侱rug impurity reference, drug standard, analytical chemistry, standard substance, organic chemical synthesis, chemical custo...
Min. Order:0
Supplier:Hubei Moxin Biotechnology Co., Ltd [
China (Mainland)] CAS No.183901-47-5 Aprepitant Impurity B Enantiomer HCl
Assay:> 95% Appearance:Solid powder Package:inquiry Transportation:inquiry Application:A metabolite of Aprepitant
Min. Order:1Gram
Supplier:BOC Sciences [
United States]
Other Product
- 1039900-47-4/2-Amino-3-fluoro-5-methylbenzoic acid
- 1172614-86-6/Cis-3-(2,5-dimethylphenyl)-8-methoxy-2-oxo-1-azaspiro(4.5)dec-3-en-4-yl beta-D-glucopyranoside
- 1230021-28-9/3-(1-(Dimethylamino)ethyl)phenyl dimethylcarbamate, (1S)-
- 946784-63-0/4-(3-Methoxyphenoxy)-2-(trifluoromethyl)aniline
- 546116-57-8/3-[4-(1,3-Benzodioxol-5-ylmethyl)piperazin-1-yl]-3-oxopropanenitrile
- 937598-44-2/3-Fluoro-4-(quinuclidin-3-yloxy)aniline
- 1217481-36-1/Fumonisin B2-13C34
- 1799329-72-8/N-(4-fluoro-3-(6-pyridin-2-yl-(1,2,4)triazolo(1,5-a)pyrimidin-2-yl)phenyl)-2,4-dimethyl-1,3-oxazole-5-carboxamide
- 898761-78-9/1-(4-Bromo-2-fluorophenyl)-3-(4-bromophenyl)propan-1-one
- 2110848-26-3/2-Chloro-8-fluoro-7-methoxyquinoline
- 1020033-70-8/(7-Methyl-[1,2,4]triazolo[4,3-a]pyridin-3-yl)methanamine
- 912342-23-5/2CB-Ind
- 924859-06-3/2-[1-(3-fluorophenyl)-1H-1,2,3-triazol-4-yl]propan-2-ol
- 34290-57-8/PtdIns-(1,2-dipalmitoyl) (ammonium salt)
- 1707358-10-8/4,4-Difluoro-1-(2-fluoro-6-(trifluoromethyl)-phenyl)piperidine
- 1261951-85-2/2-[3-(Pyrrolidinylsulfonyl)phenyl]nicotinic acid
- 886497-06-9/5-(2,4,5-Trimethylphenyl)-1,2,4-triazin-3-amine
- 924861-63-2/1-(Piperazinylsulfonyl)eth-2-ylamine
- 1810074-92-0/(R)-8-Amino-6-azaspiro[3.4]octan-5-one
- 183901-47-5/Aprepitant Impurity B Enantiomer HCl
- 1341040-31-0/C-(8-Methyl-[1,2,4]triazolo[4,3-A]pyridin-3-YL)-methylamine hydrochloride
- 902836-36-6/4-[4-(4-Methoxyphenyl)-1H-Pyrazol-1-Yl]Piperidine
- 1286734-96-0/6-Bromo-5-fluoro-3-iodo-1-methyl-1H-indazole
- 1050381-35-5/(R)-4-(8-Fluoro-2-oxo-1,2-dihydroquinazolin-3(4H)-yl)-N-(3-(7-methyl-1H-indazol-5-yl)-1-oxo-1-(4-(piperidin-1-yl)piperidin-1-yl)propan-2-yl)piperidine-1-carboxamide
- 1185303-70-1/4-[(4-Methylphenoxy)methyl]piperidine hydrochloride
- 1159822-29-3/2-(Pyrimidin-2-yloxy)benzonitrile
- 956034-45-0/Methanesulfonamide, N-methyl-N-(2-pyrrolidinylmethyl)-
- 893639-92-4/Ethyl 5-(morpholinomethyl)isoxazole-3-carboxylate
- 1314785-90-4/1-(4-Bromo-3-fluorophenyl)cyclobutanamine
- 890095-59-7/5-(chloromethyl)-3-phenylpyrazolo[1,5-a]pyrimidin-7(4H)-one